Open access · OA
via OpenAlex
Possibility of small-molecule-based pharmacotherapy for sarcopenia
Yuka Watanabe, Yuko Miyagoe‐Suzuki
The Journal of Physical Fitness and Sports Medicine · 2015 · ▲ 3 citations
Abstract
Muscle mass and strength decline with age. When severe, the loss is called sarcopenia. Sarcopenia is drawing attention worldwide, especially in highly aged societies, as a disease that should be treated. At present, we have limited tools to combat sarcopenia (e.g. resistance training and nutritional intervention), but accumulating knowledge of the molecular and cellular mechanisms of sarcopenia is accelerating the development of pharmacological therapies for sarcopenia. Because sarcopenia is a complicated pathological condition caused and modified by many aging-related factors, such as inactivity, loss of motor neurons, poor nutrition, decline of anabolic hormones, chronic inflammation, oxidative stress, impaired stem cell function, and comorbidity, the proposed target molecules or pathways for pharmacological intervention are diverse. Here we review recent progress in drug development with emphasis on small-molecule compound-based therapies and review the literature to identify new therapeutic targets to prevent, delay, or reverse sarcopenia.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.7600/jpfsm.4.73
- Canonical
- link ↗
- Fetched
- 2026-06-23 MST
Cite this
APA
Watanabe, Y., & Miyagoe‐Suzuki, Y. (2015). Possibility of small-molecule-based pharmacotherapy for sarcopenia. <em>The Journal of Physical Fitness and Sports Medicine</em>. https://doi.org/10.7600/jpfsm.4.73
Vancouver
Watanabe Y, Miyagoe‐Suzuki Y. Possibility of small-molecule-based pharmacotherapy for sarcopenia. The Journal of Physical Fitness and Sports Medicine. 2015. doi:10.7600/jpfsm.4.73.
BibTeX
@article{yuka2015Possib,
title = {Possibility of small-molecule-based pharmacotherapy for sarcopenia},
author = {Yuka Watanabe and Yuko Miyagoe‐Suzuki},
journal = {The Journal of Physical Fitness and Sports Medicine},
year = {2015},
doi = {10.7600/jpfsm.4.73},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Biological trace element research 2026
Citation only
Selenium Deficiency is a Significant Risk Factor for Sarcopenia: Evidence and Selenoprotein-Mediated Mechanisms.
International Journal of Molecular Sciences 2010
Open access · CC-BY
Oxidative Stress, Molecular Inflammation and Sarcopenia
The Egyptian Journal of Internal Medicine 2026
Open access · CC-BY
Molecular interaction mechanisms of muscle fiber type transition in aging sarcopenia and the role of exercise intervention
The Egyptian journal of internal medicine 2026
Open access · OA
Molecular interaction mechanisms of muscle fiber type transition in aging sarcopenia and the role of exercise intervention.
Journal of Cachexia Sarcopenia and Muscle 2012
Open access · CC-BY
Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass
2026
Preprint